Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuphoria Therapeutics (NEUP) Gains from Investment Securities (2022 - 2025)

Neuphoria Therapeutics (NEUP) has disclosed Gains from Investment Securities for 4 consecutive years, with $136770.0 as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities rose 168.95% to $136770.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $136770.0 through Dec 2025, up 168.95% year-over-year, with the annual reading at $91211.0 for FY2025, 75.9% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was $136770.0 at Neuphoria Therapeutics, up from $51839.0 in the prior quarter.
  • The five-year high for Gains from Investment Securities was $56.6 million in Q2 2022, with the low at $50854.0 in Q4 2024.
  • Average Gains from Investment Securities over 4 years is $7.9 million, with a median of $114160.5 recorded in 2024.
  • The sharpest move saw Gains from Investment Securities crashed 95.87% in 2023, then surged 168.95% in 2025.
  • Over 4 years, Gains from Investment Securities stood at $56.6 million in 2022, then plummeted by 95.87% to $2.3 million in 2023, then plummeted by 97.83% to $50854.0 in 2024, then soared by 168.95% to $136770.0 in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $136770.0, $51839.0, and $3.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.